FDA Inspection 991152 — OrthogenRx Inc,

OrthogenRx Inc, — FEI 3011402886

The FDA completed an inspection of OrthogenRx Inc, on Oct 20, 2016 in Doylestown, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 20, 2016
Fiscal Year
2017
Product Type
Devices
Project Area
Project Evaluation: Devices
Location
Doylestown, PA (United States)

Additional details

Postmarket Audit Inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.